Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

17.11.20	Pfizer Selects Four States For U.S. COVID-19 Immunization Pilot Program (RTTNews)
16.11.20	Pfizer Completes Combination Of Upjohn And Mylan; Viatris To Begin Trading On Nov. 17 (RTTNews)
16.11.20	Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan (Businesswire)
16.11.20	COVID-19 Vaccines - The Blues And Ease Of Cold Storage (RTTNews)
15.11.20	Week Ahead In Pharma: FDA Decisions, Data Readouts (ADMP, EIGR, KZIA, AVRO…) (RTTNews)
11.11.20	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
11.11.20	Pfizer's Abrocitinib Meets Primary & Secondary Endpoints In Late-stage Atopic Dermatitis Study (RTTNews)
11.11.20	Pfizer Announces Positive Results from Fifth Phase 3 Trial of Abrocitinib, Evaluating Safety and Efficacy Across Different Dosing Regimens (Businesswire)
11.11.20	Pfizer, BioNTech To Supply 200 Million Doses Of Their COVID-19 Vaccine Candidate To EU - Quick Facts (RTTNews)
11.11.20	Pfizer and BioNTech Reach an Agreement to Supply the EU With 200 Million Doses of Their BNT162b2 mRNA-Based Vaccine Candidate Against SARS-CoV-2 (Businesswire)
10.11.20	Pre-market Movers In Healthcare Sector: ALT, AFMD, BNTX, PFE, AZN, SUPN… (RTTNews)
10.11.20	ARNA Falls Short Of ADVICE, PFE's COVID-19 Vaccine Shows 90% Efficacy, SUPN Hit By Double Whammy (RTTNews)
10.11.20	Lilly's COVID-19 Antibody Drug Gets FDA Emergency Use Authorization For Non-hospitalized Patients (RTTNews)
09.11.20	Stock Alert: Pfizer Climbs 12% As COVID-19 Vaccine Found More Than 90% Effective (RTTNews)
09.11.20	Pfizer, BioNTech: COVID-19 Vaccine Candidate More Than 90% Effective (RTTNews)
09.11.20	Pfizer & BioNTech's COVID-19 Vaccine Candidate Shows Efficacy Rate Above 90% In Interim Analysis (RTTNews)
09.11.20	Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study (Businesswire)
06.11.20	Pfizer Reports Positive Phase 3 Study Results For Tofacitinib In Ankylosing Spondylitis (RTTNews)
06.11.20	Pfizer Announces Positive Phase 3 Study Results for XELJANZ ® (tofacitinib) in Ankylosing Spondylitis (AS) (Businesswire)
05.11.20	Pfizer Announces Details for When-Issued and Ex-Distribution Trading of Viatris and Pfizer Common Stock (Businesswire)
30.10.20	Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn (Businesswire)
27.10.20	FDA, EMA Accept Regulatory Submission For Pfizer's Abrocitinib For Atopic Dermatitis Treatment (RTTNews)
27.10.20	Pfizer Tightens FY20 Outlook Range; Q3 Adj. EPS Tops View - Quick Facts (RTTNews)
27.10.20	FDA Grants Priority Review and EMA Accepts Regulatory Submission for Pfizer’s Abrocitinib, an Oral Once-Daily JAK1 Inhibitor, for Patients 12 and Up with Moderate to Severe Atopic Dermatitis (Businesswire)
27.10.20	Pfizer Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
27.10.20	PFIZER REPORTS THIRD-QUARTER 2020 RESULTS (Businesswire)
23.10.20	Pre-market Movers In Healthcare Sector: SAVA, KTOV, PRVL, IMMP, GILD, ITRM, BBI… (RTTNews)
21.10.20	Pfizer Reports Data From Clinical Trial For 20-Valent Pneumococcal Conjugate Vaccine (RTTNews)
21.10.20	Data From Pfizer’s Adult and Pediatric Clinical Trial Programs for 20-Valent Pneumococcal Conjugate Vaccine Presented at IDWeek 2020 (Businesswire)
16.10.20	Pfizer To Apply For Emergency Use Of COVID-19 Vaccine By Late Nov. (RTTNews)
09.10.20	Pfizer Says PENELOPE-B Trial Of IBRANCE Did Not Meet Primary Endpoint - Quick Facts (RTTNews)
09.10.20	PENELOPE-B Trial of IBRANCE® (palbociclib) in Early Breast Cancer Did Not Meet Primary Endpoint (Businesswire)
08.10.20	Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency (Businesswire)
07.10.20	Pfizer, Sangamo Begin Phase 3 Dosing Study Of Giroctocogene Fitelparvovec (RTTNews)
07.10.20	Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment (Businesswire)
06.10.20	Pre-market Movers In Healthcare Sector: XTNT, BNTX, GLYC, ALNA, MGEN, IOVA, ARTL… (RTTNews)
06.10.20	Pfizer, BioNTech Begin Rolling Submission To EMA For SARS-CoV-2 Vaccine Candidate (RTTNews)
01.10.20	Pfizer's Gene Therapy Candidate For Duchenne Muscular Dystrophy Receives Fast Track designation (RTTNews)
01.10.20	Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy (Businesswire)
01.10.20	SELB Down But Not Out, PFE Takes 9.9% Stake In CStone, ZSAN Plunges, AMAG On The Block? (RTTNews)
29.09.20	GNFT Soars On LabCorp Deal, INO's COVID-19 Vaccine Trial On Partial Hold, FDA Expands Xeljanz Label (RTTNews)
28.09.20	U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis (Businesswire)
24.09.20	Pfizer Declares Fourth-Quarter 2020 Dividend (Businesswire)
24.09.20	IDEAYA Expands Clinical Trial Collaboration, Supply Agreement With Pfizer - Quick Facts (RTTNews)
24.09.20	JNJ Begins Phase 3 COVID-19 Vaccine Trial, Another Headstone In Alzheimer's Graveyard, PFE On Watch (RTTNews)
23.09.20	Pfizer Says FDA Accepts SNDA For XALKORI, Grants Priority Review - Quick Facts (RTTNews)
23.09.20	FDA Accepts Supplemental New Drug Application for Pfizer’s XALKORI® (crizotinib) for the Treatment of Pediatric ALK-positive Anaplastic Large Cell Lymphoma (Businesswire)
22.09.20	Pfizer Invites Public to View and Listen to Webcast of October 27 Conference Call with Analysts (Businesswire)
18.09.20	Pre-market Movers In Healthcare Sector: IMMP, SAVA, SNOA, CRDF, INO… (RTTNews)
17.09.20	Pre-market Movers In Healthcare Sector: SRNE, GNCA, VXRT, BNTX, INO... (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	76.62	0.39 %	K V
Part Grp Hldg	1’271.50	0.36 %	K V
Holcim	89.08	0.25 %	K V
Logitech Intl	74.82	-0.05 %	K V
Lonza Grp	540.60	-0.15 %	K V
UBS Group	27.82	-1.24 %	K V
Sika	223.10	-1.37 %	K V
Nestle	74.10	-1.49 %	K V
Swiss Re	129.60	-1.78 %	K V
Givaudan	3’961.00	-2.46 %	K V

mehr

22:34		Dow Jones-Handel aktuell: Dow Jones beendet den Mittwochshandel mit Verlusten
17:58		Pluszeichen in Europa: STOXX 50 letztendlich fester
17:58		Minuszeichen in Zürich: SMI legt letztendlich den Rückwärtsgang ein
17:58		Börse Zürich in Rot: SPI schliesst in der Verlustzone
17:58		Handel in Europa: Euro STOXX 50 präsentiert sich letztendlich fester
17:58		Freundlicher Handel in London: FTSE 100 notiert zum Ende des Mittwochshandels im Plus
17:58		Zuversicht in Frankfurt: Zum Ende des Mittwochshandels Pluszeichen im TecDAX
17:58		Aufschläge in Frankfurt: SDAX steigt zum Handelsende

22:34

Dow Jones-Handel aktuell: Dow Jones beendet den Mittwochshandel mit Verlusten

17:58

Pluszeichen in Europa: STOXX 50 letztendlich fester

17:58

Minuszeichen in Zürich: SMI legt letztendlich den Rückwärtsgang ein

17:58

Börse Zürich in Rot: SPI schliesst in der Verlustzone

17:58

Handel in Europa: Euro STOXX 50 präsentiert sich letztendlich fester

17:58

Freundlicher Handel in London: FTSE 100 notiert zum Ende des Mittwochshandels im Plus